Document is current
Any future updates will be listed below
-
Authors
Erbas, Mert Ege
Ziehfreund, Stefanie
Biedermann, Tilo
Zink, Alexander
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 11 August 2025
First Online: 9 September 2025
Declarations
:
: All study procedures were conducted in accordance with the Declaration of Helsinki. The study was approved by the ethics committee at the Technical University of Munich (Reference 129/20 S).
: Not applicable.
: Author TB was president of the German Society of Dermatology. In addition, he has either received grants, consulting fees, support for attending meetings and/or travel, and speaker’s honoraria or participated in a Data Safety Monitoring Board or Advisory Board of the following companies outside this work: AbbVie, Alk-Abello, Almirall, Boehringer-Ingelheim, Celgene-BMS, GSK, Leo Pharma, Lilly, Novartis, Sanofi-Genzyme, Regeneron, and Viatris.Author AZ is member of the German Society of Dermatology and leader of the Digital Dermatology group within this society. He has either been an advisor, received speaker’s honoraria and grants, or participated in clinical trials of the following companies outside this work: AbbVie, Almirall, Amgen, Beiersdorf Dermo Medical, Bencard Allergie, BMS, Celgene, Eli Lilly, GSK, Incyte, Janssen Cilag, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi-Aventis, and UCB Pharma.
